CDT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Conduit Pharmaceuticals Inc (CDT).


$7.06M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

CDT Market Cap. (MRY)


CDT Shares Outstanding (MRY)


CDT Assets (MRY)


Total Assets

$4.19M

Total Liabilities

$10.99M

Total Investments

$0

CDT Income (MRY)


Revenue

$0

Net Income

-$17.80M

Operating Expense

$15.42M

CDT Cash Flow (MRY)


CF Operations

-$9.68M

CF Investing

-$43.00K

CF Financing

$6.07M

CDT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

-

-

0%

-

CDT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$4,193,000 (-41.96%)

$7,224,000 (144380.00%)

$5,000 (0%)

$0

Assets Current

$2,715,000 (-52.64%)

$5,733,000 (0%)

$0 (0%)

$104,163

Assets Non-Current

$1,478,000 (-0.87%)

$1,491,000 (29720.00%)

$5,000 (-95.41%)

$108,962

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$5,000 (0%)

$0

Shareholders Equity

-$6,793,000 (-1386.43%)

-$457,000 (95.47%)

-$10,089,000 (-69.79%)

-$5,942,000

Property Plant & Equipment Net

$303,000 (0%)

$0 (0%)

$0 (0%)

$0

Cash & Equivalents

$554,000 (-86.90%)

$4,228,000 (0%)

$0 (0%)

$0

Accumulated Other Comprehensive Income

$414,000 (0.73%)

$411,000 (-39.11%)

$675,000 (1138.46%)

-$65,000

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$2,958,000

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$1,428,000 (564.19%)

$215,000 (0%)

$0 (0%)

$0

Accumulated Retained Earnings (Deficit)

-$29,101,000 (-157.55%)

-$11,299,000 (-4.91%)

-$10,770,000 (-83.26%)

-$5,877,000

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Debt

$7,457,000 (657.06%)

$985,000 (-83.83%)

$6,093,000 (713.48%)

$749,000

Debt Current

$7,350,000 (646.19%)

$985,000 (0%)

$0 (0%)

$0

Debt Non-Current

$107,000 (0%)

$0 (0%)

$6,093,000 (713.48%)

$749,000

Total Liabilities

$10,986,000 (43.03%)

$7,681,000 (-23.91%)

$10,094,000 (69.88%)

$5,942,000

Liabilities Current

$10,741,000 (496.39%)

$1,801,000 (-30.30%)

$2,584,000 (15.62%)

$2,235,000

Liabilities Non-Current

$245,000 (-95.83%)

$5,880,000 (-21.70%)

$7,510,000 (102.59%)

$3,707,000

CDT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$12,041,000 (132.81%)

$5,172,000 (69.63%)

$3,049,000 (5.50%)

$2,890,000

Research & Development Expense

$3,378,000 (3653.33%)

$90,000 (143.24%)

$37,000 (32.14%)

$28,000

Operating Expenses

$15,419,000 (193.03%)

$5,262,000 (66.52%)

$3,160,000 (-0.41%)

$3,173,000

Interest Expense

$1,506,000 (613.74%)

$211,000 (0%)

$0 (0%)

$0

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$17,802,000 (-3227.48%)

-$535,000 (89.05%)

-$4,887,000 (-33.63%)

-$3,657,000

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income

-$17,802,000 (-3227.48%)

-$535,000 (89.05%)

-$4,887,000 (-33.63%)

-$3,657,000

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$17,802,000 (-3227.48%)

-$535,000 (89.05%)

-$4,887,000 (-33.63%)

-$3,657,000

Weighted Average Shares

$867,096 (-98.71%)

$66,973,906 (-96.65%)

$2,000,000,000 (100.00%)

$1,000,000,000

Weighted Average Shares Diluted

$867,096 (-98.72%)

$67,893,881 (-96.61%)

$2,000,000,000 (100.00%)

$1,000,000,000

Earning Before Interest & Taxes (EBIT)

-$16,296,000 (-4929.63%)

-$324,000 (93.37%)

-$4,887,000 (-33.63%)

-$3,657,000

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0

Operating Income

-$15,419,000 (-193.03%)

-$5,262,000 (-66.52%)

-$3,160,000 (0.41%)

-$3,173,000

CDT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$43,000 (-105.93%)

$725,000 (496.17%)

-$183,000 (0%)

$0

Net Cash Flow from Financing

$6,067,000 (-44.49%)

$10,929,000 (346.45%)

$2,448,000 (28.98%)

$1,898,000

Net Cash Flow from Operations

-$9,682,000 (-25.33%)

-$7,725,000 (-240.91%)

-$2,266,000 (-5.35%)

-$2,151,000

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,674,000 (-186.90%)

$4,228,000 (0%)

$0 (0%)

-$252,000

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$357,000 (-7.85%)

-$331,000 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$8,000 (-99.26%)

$1,082,000 (631.08%)

$148,000 (0%)

$0

Capital Expenditure

-$51,000 (0%)

$0 (0%)

$0 (0%)

$0

Issuance (Repayment) of Debt Securities

$2,450,000 (7.17%)

$2,286,000 (106.50%)

$1,107,000 (60.90%)

$688,000

Issuance (Purchase) of Equity Shares

$3,441,000 (-60.19%)

$8,643,000 (0%)

$0 (0%)

$0

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

-$16,000 (-105.35%)

$299,000 (29800.00%)

$1,000 (0.00%)

$1,000

Share Based Compensation

$1,834,000 (821.61%)

$199,000 (0%)

$0 (0%)

$0

Depreciation Amortization & Accretion

$546,000 (0%)

$0 (0%)

$0 (0%)

$0

CDT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

291.00% (3886.30%)

7.30% (-92.47%)

97.00%

-

Return on Average Assets (ROAA)

-462.10% (-4063.06%)

-11.10% (-131.25%)

-4.80%

-

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

478.30% (1523.51%)

-33.60% (-600.00%)

-4.80%

-

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-0.33 (99.93%)

-455 (-11374900.00%)

-0

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-1.04 (99.86%)

-735.06 (-4085.78%)

-17.56

-

Debt to Equity Ratio (D/E)

-1.62 (90.38%)

-16.81 (-1580.70%)

-1 (0.00%)

-1

Earnings Per Share (EPS)

-20.53 (-205200.00%)

-0.01 (100.00%)

-2,444 (33.17%)

-3,657

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-11.22 (-9660.87%)

-0.12 (-11400.00%)

-0 (50.00%)

-0

Book Value Per Share (BVPS)

-7.83 (-111814.29%)

-0.01 (-40.00%)

-0.01 (16.67%)

-0.01

Tangible Assets Book Value Per Share (TABVPS)

4.84 (4377.78%)

0.11 (0%)

0 (0%)

0

Enterprise Value Over EBIT (EV/EBIT)

-1 (99.90%)

-1,021 (-2736.11%)

-36

-

Enterprise Value Over EBITDA (EV/EBITDA)

-0.61 (99.94%)

-1,021.38 (-2728.91%)

-36.1

-

Asset Turnover

0 (0%)

0 (0%)

0

-

Current Ratio

0.25 (-92.05%)

3.18 (0%)

0 (0%)

0.05

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$9,733,000 (-25.99%)

-$7,725,000 (-240.91%)

-$2,266,000 (-5.35%)

-$2,151,000

Enterprise Value (EV)

$9,650,371 (-97.08%)

$330,926,389 (87.55%)

$176,445,740

-

Earnings Before Tax (EBT)

-$17,802,000 (-3227.48%)

-$535,000 (89.05%)

-$4,887,000 (-33.63%)

-$3,657,000

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$15,750,000 (-4761.11%)

-$324,000 (93.37%)

-$4,887,000 (-33.63%)

-$3,657,000

Invested Capital

$355,000 (-83.72%)

$2,180,000 (-37.87%)

$3,509,000 (336.14%)

-$1,486,000

Working Capital

-$8,026,000 (-304.12%)

$3,932,000 (252.17%)

-$2,584,000 (-21.27%)

-$2,130,837

Tangible Asset Value

$4,193,000 (-41.96%)

$7,224,000 (0%)

$0 (0%)

$0

Market Capitalization

$7,055,371 (-97.90%)

$335,924,389 (89.60%)

$177,173,812

-

Average Equity

-$6,118,000 (16.94%)

-$7,365,750 (-46.15%)

-$5,039,715

-

Average Assets

$3,852,000 (-20.00%)

$4,815,000 (-95.30%)

$102,463,244

-

Invested Capital Average

-$3,407,000 (-453.42%)

$964,000 (-99.06%)

$102,573,371

-

Shares

1,028,480 (-98.61%)

73,829,536 (327.12%)

17,285,250

-